Crystal Growth & Design
Article
5
1.4, 49.0, 31.2, 29.2, 28.9, 28.9, 28.8, 28.8, 28.6, 28.3, 25.4, 22.0, 13.9.
1-Dodecyl-12-(2-(4-((4-methylphenyl)diazenyl)phenoxy)ethyl)-
+
1
MS (FAB): m/z = 208 (100%, 4,4′-dimethylazobenzene ), 340 (15%,
K /2), 444 (50%, K -dodecylimidazole), 679 (54% K -H ), 761
imidazolium Bromide 2c. Yield: 63%, H NMR (200 MHz, CDCl
3
) δ:
+
2
+2
+2
+
10.88 (s, 1H), 7.88 (d, J = 9.0 Hz, 2H), 7.78 (d, J = 8.3 Hz, 2H), 7.55 (s,
1H), 7.29 (d, J = 8.6 Hz, 2H), 7.20−7.14 (m, 1H), 7.00 (d, J = 9.0 Hz,
2H), 5.07−4.98 (m, 2H), 4.58−4.48 (m, 2H), 4.25 (t, J = 7.5 Hz, 2H),
+
2
−
(
15%, K +Br ). Elemental analysis: calcd % for C H Br N (M = 840
44 68 2 6
g/mol): C 62.85, H 8.15, N 9.99 found: C 58.26, H 7.97, N 9.98.
,4′-Bis(N-tetradecylimidazole-methyl)azobenzene Dibromide
2
.42 (s, 3H), 1.91 (d, J = 6.5 Hz, 2H), 1.36−1.19 (m, 18H), 0.87 (t, J =
4
1
13
(1e). Yield: 40%, H NMR (200 MHz, DMSO) δ 9.33 (s, 2H), 7.92
6.4 Hz, 3H). C NMR (50 MHz, CDCl ) δ: 159.6, 150.7, 147.7, 141.3,
3
(
d, J = 8.3 Hz, 4H), 7.85 (s, 2H), 7.62 (d, J = 8.6 Hz, 4H), 5.54 (s, 4H),
137.4, 129.8, 124.7, 123.5, 122.7, 121.5, 114.8, 66.7, 50.4, 49.5, 31.9,
4
3
1
2
.19 (t, J = 6.8 Hz, 4H), 1.86−1.70 (m, 4H), 1.21 (s, 45H), 0.84 (t, J =
.3 Hz, 6H). 13C NMR (50 MHz, DMSO) δ: 151.8, 138.3, 136.3, 129.4,
23.1, 122.9, 122.7, 51.5, 49.0, 35.8, 31.2, 29.2, 28.9, 28.9, 28.8, 28.8,
8.6, 28.3, 25.4, 22.0, 13.9. MS (FAB): m/z = 208 (83%, 4,4′-
30.3, 29.6, 29.6, 29.4, 29.4, 29.0, 26.3, 22.7, 21.5, 14.2. MS (FAB): m/z =
+
+
405 (60%, Didodecylimidazol ), 475 (100% K ). Elemental analysis:
calcd % for C30 O (M = 555 g/mol): C 64.85, H 7.80, N 10.08
H43BrN
4
found: C 65.1, H 8.06, N 9.95.
+
+2
dimethylazobenzene ), 368 (37%, K /2), 461 (100%, ditetradecylimi-
Synthesis of 1-(4-((6-Bromohexyl)oxy)phenyl)-2-(4-
methylphenyl)diazene 15b. This compound was synthesized by the
same procedure described for the synthesis of 15a. From 14-
methylphenyldiazenylphenol (13) (3 g, 14.15 mmol), dibromohexane
+
2
+2
dazolium), 472 (79%, K -tetradecylimidazole), 539 (19%, K -
C H ), 735 (69% K -H ), 817 (23%, K +Br ). Elemental analysis:
calcd % for C H Br N (M = 897 g/mol): C 64.3, H 8.5, N 9.4 found:
C 60.1, H 8.15, N 9.73.
Synthesis of 4-Methylphenyldiazenylphenol 13. Ten grams of p-
toluidine (93.45 mmol) and 25 mL of concentrated hydrochloric acid
were dissolved in 111 mL of water and cooled to 0 °C. A total of 6.45 g of
NaNO (93.45 mmol) in 15 mL of water were added slowly. A solution
of phenol (8.77g, 93.45 mmol), Na CO (10.18 g, 96 mmol), and
NaOH (3.84 g, 96 mmol) was added dropwise, and the mixture was
stirred for another 4 h. After the pH was adjusted to 7 with hydrochloric
acid, the precipitated product was filtered off, washed with water, and
dried under a vacuum at room temperature for 24 h.
+
2
+
+2
−
14
29
48
76
2
6
(
10.36 g, 42.45 mmol) and 7.22 g of potassium carbonate, 15b was
obtained as an orange solid.
1
H NMR (200 MHz, acetone) δ: 7.82−7.72 (m, 2H), 7.66 (d, J = 8.3
Hz, 2H), 7.23 (d, J = 8.1 Hz, 2H), 7.03−6.93 (m, 2H), 4.00 (t, J = 6.4 Hz,
H), 3.40 (t, J = 6.7 Hz, 2H), 2.29 (s, 3H), 1.79−1.71 (m, 6H), 1.64−
.57 (m, 2H), 1.42 (dd, J = 9.0, 5.5 Hz, 4H).
2
1
2
2
3
Synthesis of 1-Alkyl-(2-(4-((4-methylphenyl)diazenyl)phenoxy)-
hexyl)imidazolium Bromide 3a−e. This compound was synthesized
by the same procedure described for the synthesis of 2a−c. A solution of
1
5b and 1 equiv of the respective alkylimidazole was heated under reflux
in acetonitrile for 3 days. After being cooled to room temperature the
solution was poured into cold ethyl acetate and kept at −40 °C for 12 h.
The orange precipitate was filtered off and dried under a vacuum at
room temperature overnight.
1
Yield: 11.9 g (60%), H NMR (200 MHz, acetone) δ: 7.88−7.70 (m,
4H), 7.35 (d, J = 8.0 Hz, 2H), 7.06−6.95 (m, 2H), 2.41 (s, 3H).
Synthesis of 1-(4-((2-Bromoethyl)oxy)phenyl)-2-(4-
methylphenyl)diazene 15a. A mixture of 3 g (14.15 mmol) of 13,
1
-Octyl-8-(2-(4-((4-methylphenyl)diazenyl)phenoxy)hexyl)-
3.64 mL (42.45 mmol) of 1,2-dibromoethane, and 7.22 g (52.36 mmol)
1
imidazolium Bromide 3a. Yield: 70%, H NMR (200 MHz, CDCl ) δ:
3
of K CO in 100 mL of acetonitrile was heated under reflux for 20 h.
2
3
1
(
2
4
0.76 (s, 1H), 7.76 (dd, J = 20.0, 8.6 Hz, 4H), 7.24 (s, 2H), 7.16−7.11
After being cooled to room temperature the suspension was poured into
water and extracted with dichloromethane. The combined organic
phases were dried with sodium sulfate and filtered, and the solvent was
removed under a vacuum. The product was dried under a vacuum at
m, 1H), 6.91 (d, J = 8.9 Hz, 2H), 4.40−4.18 (m, 4H), 3.97 (t, J = 6.1 Hz,
H), 2.35 (s, 3H), 1.85 (ddd, J = 24.4, 10.8, 5.3 Hz, 6H), 1.56−1.33 (m,
13
H), 1.29−1.13 (m, 10H), 0.80 (t, J = 6.2 Hz, 3H). C NMR (50 MHz,
CDCl ) δ: 161.4, 150.9, 147.0, 140.9, 137.7, 129.8, 124.7, 122.6, 121.8,
3
room temperature for 20 h to give an orange powder.
1
2
2
21.7, 114.8, 67.9, 50.3, 50.1, 31.8, 30.4, 29.1, 29.0, 28.9, 26.4, 25.9, 25.6,
1
Yield: 1,7 g (38%), H NMR (200 MHz, CDCl ) δ: 7.96−7.86 (m,
+
3
2.7, 21.6, 14.2. MS (FAB): m/z = 475 (100%, K ), 1031 (2%
2
4
H), 7.84−7.74 (m, 2H), 7.30 (d, J = 8.0 Hz, 2H), 7.07−6.97 (m, 2H),
.38 (t, J = 6.3 Hz, 2H), 3.68 (t, J = 6.3 Hz, 2H), 2.43 (s, 3H).
Synthesis of 1-Alkyl-(2-(4-((4-methylphenyl)diazenyl)phenoxy)-
+
−
*K +Br ). Elemental analysis: calcd % for C H BrN O (M = 555 g/
30
43
4
mol): C 64.85, H 7.80, N 10.08 found: C 63.51, H 8.13, N 9.79.
-Decyl-10-(2-(4-((4-methylphenyl)diazenyl)phenoxy)hexyl)-
1
ethyl)imidazolium Bromide 2 a−c. A solution of 15a and 1 equiv of
the respective alkylimidazolide was heated under reflux in acetonitrile
for 3 days. After being cooled to room temperature the solution was
poured into cold ethyl acetate and kept at −40 °C for 12 h. The orange
precipitate was filtered off and dried under a vacuum at room
temperature overnight.
1
imidazolium Bromide 3b. Yield: 51%, H NMR (200 MHz, CDCl ) δ:
3
1
7
4
=
(
1
2
(
0.81 (s, 1H), 7.82 (dd, J = 19.9, 8.6 Hz, 4H), 7.29 (d, J = 5.5 Hz, 2H),
.23−7.19 (m, 1H), 6.97 (d, J = 8.9 Hz, 2H), 4.35 (dt, J = 17.9, 7.5 Hz,
H), 4.03 (t, J = 6.1 Hz, 2H), 2.41 (s, 3H), 1.97−1.77 (m, 6H), 1.47 (d, J
13
10.7 Hz, 4H), 1.34−1.20 (m, 14H), 0.86 (t, J = 6.4 Hz, 3H). C NMR
50 MHz, CDCl ) δ: 161.4, 150.9, 147.0, 140.9, 137.9, 129.8, 124.7,
3
1
-Octyl-8-(2-(4-((4-methylphenyl)diazenyl)phenoxy)ethyl)-
22.6, 121.7, 121.6, 114.8, 67.9, 50.3, 50.1, 31.9, 30.4, 29.6, 29.5, 29.4,
1
imidazolium Bromide 2a. Yield: 54%, H NMR (200 MHz, CDCl ) δ:
3
9.1, 28.9, 26.4, 26.0, 25.6, 22.8, 21.6, 14.2. MS (FAB): m/z = 503
1
7
4
0.59 (s, 2H), 7.75 (dd, J = 19.1, 8.6 Hz, 4H), 7.58 (s, 1H), 7.22 (d, J =
.3 Hz, 2H), 7.19 (s, 1H), 6.94 (d, J = 9.0 Hz, 2H), 5.02−4.88 (m, 2H),
.52−4.39 (m, 2H), 4.28−4.12 (m, 2H), 2.35 (s, 3H), 1.83 (d, J = 6.7
+
+
−
100%, K ), 1087 (1.2%, 2*K +Br ). Elemental analysis: calcd % for
C H BrN O (M = 583 g/mol): C 65.85, H 8.12, N 9.60 found: C 63.9,
3
2
47
4
H 8.14, N 9.23.
-Dodecyl-12-(2-(4-((4-methylphenyl)diazenyl)phenoxy)hexyl)-
13
Hz, 2H), 1.29−1.11 (m, 10H), 0.78 (t, J = 5.8 Hz, 3H). C NMR (50
MHz, CDCl ) δ: 159.6, 150.7, 147.7, 141.3, 137.4, 129.8, 124.7, 123.5,
1
1
3
imidazolium Bromide 3c. Yield: 66%, H NMR (200 MHz, Acetone) δ:
1
2
22.7, 121.5, 114.8, 66.7, 50.4, 49.5, 31.7, 30.3, 29.1, 28.9, 26.3, 22.6,
1.5, 14.1. MS (FAB): m/z = 419 (100%, K ). Elemental analysis: calcd
1
9
0.29 (s, 1H), 7.94−7.73 (m, 6H), 7.36 (d, J = 8.1 Hz, 2H), 7.11 (d, J =
.1 Hz, 2H), 4.45 (dt, J = 11.3, 7.3 Hz, 4H), 4.13 (t, J = 6.4 Hz, 2H), 2.42
+
%
for C H BrN O (M = 499 g/mol): C 62.52, H 7.06, N 11.22 found:
(s, 3H), 1.82 (dd, J = 16.9, 9.2 Hz, 6H), 1.61−1.43 (m, 4H), 1.30 (d, J =
26
35
4
17.1 Hz, 18H), 0.86 (t, J = 6.4 Hz, 3H). 13C NMR (50 MHz, CDCl ) δ:
C 62.27, H 7.34, N 11.35.
-Decyl-10-(2-(4-((4-methylphenyl)diazenyl)phenoxy)ethyl)-
imidazolium Bromide 2b. Yield: 49%, H NMR (200 MHz, CDCl ) δ:
3
1
161.4, 150.8, 146.9, 140.9, 137.6, 129.8, 124.7, 122.6, 121.9, 121.7, 114.8,
1
3
67.9, 50.3, 50.0, 31.9, 30.4, 30.3, 29.7, 29.6, 29.5, 29.4, 29.1, 28.9, 26.4,
10.99 (s, 1H), 7.88 (d, J = 8.9 Hz, 2H), 7.78 (d, J = 8.3 Hz, 2H), 7.55 (s,
+
2
(
6
5.9, 25.5, 22.8, 21.6, 14.2. MS (FAB): m/z = 531 (100%, K ), 1143
+
−
1H), 7.31 (s, 2H), 7.18 (s, 1H), 6.99 (d, J = 9.0 Hz, 2H), 5.03 (d, J = 4.7
1.7%, 2*K +Br ). Elemental analysis: calcd % for C H BrN O (M =
34 51 4
Hz, 2H), 4.53 (d, J = 4.5 Hz, 2H), 4.30−4.17 (m, 2H), 2.42 (s, 3H),
11 g/mol): C 66.76, H 8.4, N 9.16 found: C 66.54, H 9.44, N 9.07.
13
2
.03−1.82 (m, 2H), 1.42−1.14 (m, 18H), 0.86 (t, J = 6.4 Hz, 3H).
C
1
-Tetradecyl-12-(2-(4-((4-methylphenyl)diazenyl)phenoxy)hexyl)-
1
NMR (50 MHz, CDCl ) δ: 159.6, 150.8, 147.9, 141.4, 138.3, 129.9,
imidazolium Bromide 3d. Yield: 48%, H NMR (200 MHz, CD CN)
3
3
1
2
4
24.8, 123.5, 122.8, 121.0, 114.8, 67.0, 49.6, 31.9, 30.3, 29.5, 29.3, 29.1,
δ: 8.68 (s, 1H), 8.04−7.81 (m, 4H), 7.49 (dd, J = 6.0, 4.8 Hz, 4H), 7.16
+
6.4, 22.8, 21.6, 14.2. MS (FAB): m/z = 349 (100%, Didecylimidazol ),
(dt, J = 4.3, 3.1 Hz, 2H), 4.33−4.10 (m, 6H), 2.53 (s, 3H), 1.91−1.81
+
13
47 (97% K ). Elemental analysis: calcd % for C H BrN O (M = 527
(m, 6H), 1.75−1.56 (m, 4H), 1.36 (s, 22H), 0.98 (t, J = 6.5 Hz, 3H). C
28
39
4
g/mol): C 63.75, H 7.45, N 10.62 found: C 65.03, H 8.75, N 10.71.
NMR (50 MHz, CDCl ) δ: 161.5, 150.8, 146.9, 141.0, 137.8, 129.8,
3
C
Cryst. Growth Des. XXXX, XXX, XXX−XXX